Yue Shentu

Yue Shentu

Daiichi-Sankyo Co., Ltd - / Japan
Natural Sciences / Mathematical Sciences
AD Scientific Index ID: 4468667
person_outline Yue Shentu's MOST POPULAR ARTICLES
1-) Pembrolizumab versus chemotherapy for PD-L1–positive non–small-cell lung cancer New England Journal of Medicine 375 (19), 1823-1833, 2016
2-) Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial The lancet 387 (10027), 1540-1550, 2016
3-) Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes Diabetes care 34 (12), 2560-2566, 2011
4-) Phase 3 study of carboplatin-paclitaxel/nab-paclitaxel (Chemo) with or without pembrolizumab (Pembro) for patients (Pts) with metastatic squamous (Sq) non-small cell lung … Journal of Clinical Oncology 36 (15_suppl), 105-105, 2018
5-) Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial Annals of Oncology 30 (2), 281-289, 2019